Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for prevention of progression of mild portal hypertension in compensated cirrhosis
2010-021593-11Phase 3Active
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of simvastatin in Portal Hypertension (PH) and Cirrhosis (2 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Progression to clinically significant portal hypertension. Started Jan 2011; status: active.
02
Drugs
simvastatin
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on 2010-021593-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021593-11.